848192-93-8 Usage
General Description
3-cyclopropylazetidin-3-ol hydrochloride is a chemical compound that belongs to the class of azetidines, which are four-membered ring heterocycles. It is a hydrochloride salt of 3-cyclopropylazetidin-3-ol, and is commonly used as a pharmaceutical intermediate in the synthesis of various drugs. The presence of the cyclopropyl group in its structure imparts certain unique properties to the compound, making it useful in medicinal chemistry. It has been studied for its potential biological activities, including as an anticonvulsant and an inhibitor of GABA uptake. 3-cyclopropylazetidin-3-ol hydrochloride has the potential to be a valuable building block in the development of new pharmacologically active compounds for various therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 848192-93-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,1,9 and 2 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 848192-93:
(8*8)+(7*4)+(6*8)+(5*1)+(4*9)+(3*2)+(2*9)+(1*3)=208
208 % 10 = 8
So 848192-93-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H11NO.ClH/c8-6(3-7-4-6)5-1-2-5;/h5,7-8H,1-4H2;1H
848192-93-8Relevant articles and documents
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
-
Page/Page column 78, (2017/01/26)
Provided are compounds of formula (I) or a pharmaceutically acceptable salts or stereoisomer thereof, which are PI3K-delta inhibitors, and are useful for the treatment of PI3K-delts-mediated diseases such as inflammation, asthma, COPD and cancer.
TAXANE COMPOUND WITH AZETIDINE RING STRUCTURE
-
Page/Page column 15, (2008/12/06)
A compound represented by the general formula (1) [X1 and X2 represent hydrogen atom, a halogen atom, hydroxyl group and the like, R1 represents a phenyl group, R2 represents an alkyl group, an alkenyl group, or
AZETIDINYL QUINOLONES AS ANTIBACTERIAL AGENTS
-
Page 47-48, (2008/06/13)
Compounds of formula (I) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compoun
